2,434 results on '"*ATOVAQUONE"'
Search Results
2. Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML) (ATACC AML)
3. Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
4. Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)
5. Tafenoquine for Relapsing Babesiosis: A Case Series.
6. Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC (ARCADIAN)
7. Inhibition of Wnt Signaling by Atovaquone Inhibits Gastric Cancer and Enhances Chemotherapy Effectiveness Through Activation of Casein Kinase 1α.
8. British HIV Association guidelines on the management of opportunistic infection in people living with HIV: Considerations in pregnancy 2024.
9. Safety and Efficacy of NF135 CPS Immunization (CPS135)
10. Atovaquone enhances antitumor efficacy of TCR-T therapy by augmentation of ROS-induced ferroptosis in hepatocellular carcinoma.
11. Synergistic Chemo-Photothermal Therapy of Breast Cancer Based on Mesoporous Polydopamine Nanoparticles Decorated with Atovaquone.
12. Repeated imidocarb treatment failure suggesting emerging resistance of Babesia canis in a new endemic area in north-eastern Germany
13. Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway
14. A Safe and Effective Atovaquone-Proguanil Therapeutic Protocol for the Treatment of Avian Malaria by Plasmodium relictum in Snowy Owl (Bubo scandiacus).
15. Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway.
16. Formulation and evaluation of atovaquone-loaded macrophage-derived exosomes against Toxoplasma gondii: in vitro and in vivo assessment
17. Babesia negevi infection in dogs and response to treatment
18. Atoguanil BA Study
19. Atovaquone exerts its anticancer effect by inhibiting Na+/K+-ATPase ion transport in canine cancer cells
20. Modulating tumour metabolism enhances gold nanoparticle radiosensitisation in HPV-negative head and neck cancer
21. Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection
22. Atovaquone smart lipid system: Design, statistical optimization, and in-vitro evaluation
23. Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature.
24. Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments.
25. Atovaquone for Treatment of COVID-19
26. A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
27. A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides
28. Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
29. Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children
30. A Case of Severe Pneumocystis Pneumonia in an HIV-Negative Patient Successfully Treated with Oral Atovaquone
31. Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers
32. Editorial: Chemokine receptors and signaling in wound healing
33. In vivo activity and atom pair fingerprint analysis of MMV665941 against the apicomplexan parasite Babesia microti, the causative agent of babesiosis in humans and rodents.
34. Barriers to Timely Diagnosis and Treatment of Vector-Borne Diseases in a Changing Climate: A Case Report.
35. Modulating tumour metabolism enhances gold nanoparticle radiosensitisation in HPV-negative head and neck cancer.
36. Toxoplasmosis
37. Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis. (MALRAB)
38. Proguanil and atovaquone use is associated with lower colorectal cancer risk: a nationwide cohort study
39. Validation of atovaquone plasma levels by liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring in pediatric patients
40. Drug Combinations of Atovaquone-Proguanil (AP) With ACT (APACT)
41. The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia (ASAP)
42. DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria
43. Babesia microti Variant With Multiple Resistance Mutations Detected in an Immunocompromised Patient Receiving Atovaquone Prophylaxis.
44. Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated.
45. Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients
46. A Safe and Effective Atovaquone-Proguanil Therapeutic Protocol for the Treatment of Avian Malaria by Plasmodium relictum in Snowy Owl (Bubo scandiacus)
47. Controlled Human Malaria Infection Model for Evaluation of Transmission-blocking Interventions - Study 2 (CHMI-trans2)
48. A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI) (ECG-CHMI)
49. Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis
50. Safety and Efficacy Study of IV Artesunate to Treat Malaria
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.